Cancer of the anal region

Lisa Licitra, Silvia Spinazzé, Roberto Doci, T. R Jeffry Evans, Gunnar Tanum, Michel Ducreux

Research output: Contribution to journalArticlepeer-review


Cancer of the anal region represents 3-3.5% of all anorectal tumours. The peak incidence is between 58 and 64 years. Since 1960 an increased incidence among men younger than 45 years, and among women has been observed. The number of women diagnosed with anal canal cancer (7 per 1 000 000 person per years) is twice as much as that of men, while anal margins cancers are more frequent in men (4 per 1 000 000 person per years). Tumour extension determines the different treatment strategies, aiming at definite cure, with a conservative approach. Small tumours can be resected without mutilating surgery, while for larger tumours combination of chemotherapy and radiotherapy is the standard treatment, even though a combination of chemotherapy and radiotherapy has been recently introduced. Long-term quality of life (QOL) scores are acceptable, with the exception of patients who experience severe anal dysfunction.

Original languageEnglish
Pages (from-to)77-92
Number of pages16
JournalCritical Reviews in Oncology/Hematology
Issue number1
Publication statusPublished - 2002


  • Anal region
  • Anorectal tumours
  • Cancer

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology

Fingerprint Dive into the research topics of 'Cancer of the anal region'. Together they form a unique fingerprint.

Cite this